Navigation Links
International network to study the causes behind IBS
Date:1/28/2013

Europe-wide network GENIEUR including researchers from Sahlgrenska Academy, University of Gothenburg, Sweden, and Karolinska Institutet, Sweden, launch program for understanding the causes and improving the diagnosis and treatment of irritable bowel syndrome

For the first time, scientists from 19 European countries have joined forces to form an interdisciplinary network for investigating the causes of irritable bowel syndrome (IBS), in the hope to improve its diagnosis and treatment.

The European Science Foundation funded network GENIEUR (Genes in Irritable Bowel Syndrome Europe) aims to identify genes and DNA variants that may contribute to increase one's susceptibility to develop bowel symptoms.

Today, IBS affects more than 10 percent of the general population in Sweden, and is the most common cause of work absenteeism after common colds. Its diagnosis is based on a combination of symptoms including abdominal pain, bloating, constipation, and diarrhea, which all strongly impact patients' quality of life. Because of the unknown etiology there is currently no cure, and remedies can only alleviate symptoms and are effective in some patients but not in others.

Over 70 research groups participate in the GENIEUR network, which is headed by Dr Beate Niesler at Heidelberg University Hospital's Institute of Human Genetics, and includes research teams from the Sahlgrenska Academy, University of Gothenburg and Karolinska Institutet.

"Our goal is to use the knowledge of researchers with different expertise in order to solve the mystery of IBS", says Professor Magnus Simren, from the Department of Internal Medicine and Clinical Nutrition at the Sahlgrenska Academy, University of Gothenburg, who is also co-Chair of the GENIEUR initiative and head of a research group focusing on mechanisms underlying the symptoms of IBS.

"IBS is only modestly inherited, and there are so far very few examples of known predisposing genes" adds docent Mauro D'Amato from Karolinska Institutet's Department of Biosciences and Nutrition, member of the GENIEUR management committee and leader of the team who discovered the involvement of TNFSF15 and NPSR1 genes in IBS.

"We need very large numbers of thoroughly-characterized patients in order to increase our chances to detect true genetic predisposing factors".

For this purpose, the teams in GENIEUR aim to establish a large IBS biobank of clinical material from patients and healthy controls.

In so doing, they are also aiming to identify reliable biomarkers and compile a catalogue of criteria to precisely assign patients to individual clinical subgroups.

Besides gastroenterologists and human geneticists, the network also includes nutritionists, psychiatrists, immunologists, physiologists, neurobiologists, microbiologists, bioinformatic specialists and epidemiologists.

"With this broad knowledge included, the potential to achieve clinically important discoveries for this large group of patients is tremendous" says Prof Simren. More information is available at www.genieur.eu.


'/>"/>
Contact: Magnus Simren
magnus.simren@medicine.gu.se
University of Gothenburg
Source:Eurekalert

Related medicine news :

1. GeneCell International and its Subsidiary Celulas Madre Latin America Opens State-of-the-Art Clinical Laboratory, BIOCEMA, to Serve Thousands of Families in Venezuela
2. At least 1 in 5 were infected in flu pandemic, international study suggests
3. Xocai's New Xe Product Provides An Incentive For Marketing Xocolate International Corporation (MXI Corp) Distributors To Launch Their Business To A Whole New Level
4. TekLink International Inc. Announces 30% Increase in Revenue for 2012
5. A Delicious, And Healthy New Seasonal Hot Chocolate Beverage, Xocai's Sipping Xocolate, Has Been Released By Marketing Xocolate International Corporation (MXI Corp)
6. Natural Source International Introduces New 'Recipe For Health'
7. AkAsha International Launches Children's Book Series
8. The Leader In Healthy Chocolate; Marketing Xocolate International Corporation (MXI Corp) Expands Their Operations To Hong Kong, Xocai Now Available On Five Continents
9. Law Firm of Garcia & Phan Settles Another "Pre-litigation Settlement" for Online Trademark/Copyright Infringement on Behalf of their Client CortiSLIM® International
10. Benefit Specialists Deems International Health Insurance a Must-Have for Spring Vacations
11. ASH international clinical collaboration replicates high cure rate of APL in developing countries
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/20/2017)... ... January 20, 2017 , ... “God's Miracle Man: Against All Odds”: an ... of published author, Keith C. A. Tucker, son of Minister Delores Pinnock and a ... by Reverend Mark Hardy , “While sitting up in bed, I felt a pounding ...
(Date:1/19/2017)... ... January 19, 2017 , ... Next week after January 20th, the fear ... political games that circumvent health needs of over 30 million. Many interviews with Dr. ... and needs government public servants were suppose to prioritize. Interviews provided below. ...
(Date:1/19/2017)... (PRWEB) , ... January 19, 2017 , ... This month, ... announced that the name of their drug rehab center in Delray Beach, Florida has ... recognize that not only stars such as Philip Seymour Hoffman and Chris Farley are ...
(Date:1/19/2017)... New York (PRWEB) , ... January 19, 2017 ... ... high definition dynamic telemedicine solutions, has recently unveiled impressive transportable capabilities with their ... newly designed product is an extension to RMT technology that delivers HD, dynamic, ...
(Date:1/19/2017)... ... January 19, 2017 , ... Catalent Pharma ... drugs, biologics and consumer health products, today announced that it will be co-hosting ... in innovative excipients and drug delivery solutions to health industries worldwide. The one ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... Pfizer joins Astex, AstraZeneca, ... Consortium   Major research investment to ...   The Milner Therapeutics Institute today ... a partner to the Milner Therapeutics Consortium. Pfizer has ... transfer of materials between industry and academia and allocation ...
(Date:1/19/2017)... , January 19, 2017 The global  pacemaker market ... report by Grand View Research, Inc. The heightening prevalence of cardiac conditions coupled ... growth of Pacemaker globally. In addition, technological enhancements in these devices are supporting ... ... Grand View Research Logo ...
(Date:1/19/2017)... LONDON , Jan. 18, 2017 The ... provides understanding and access to partnering deals and agreements ... - Trends in partnering deals - Top deals by ... stage of development, technology type The report provides ... entered into by the world,s leading healthcare companies. ...
Breaking Medicine Technology: